{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:11:45Z","timestamp":1793909505391,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jinorgbio.2022.112108","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:49:00Z","timestamp":1671274140000},"page":"112108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Anticancer and antimicrobial activity of new copper (II) complexes"],"prefix":"10.1016","volume":"240","author":[{"given":"Alina","family":"Climova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Pivovarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Szczesio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Gobis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmara","family":"Ziembicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Korga-Plewko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kubik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Iwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Antos-Bielska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Krzy\u017cowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Czylkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jinorgbio.2022.112108_bb0005","first-page":"1","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013","volume":"01","author":"Ostrom","year":"2016","journal-title":"Neuro-Oncology"},{"issue":"2","key":"10.1016\/j.jinorgbio.2022.112108_bb0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11060-020-03451-6","article-title":"Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis","volume":"147","author":"Lina","year":"2020","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0015","doi-asserted-by":"crossref","DOI":"10.15586\/codon.glioblastoma.2017.ch8","article-title":"Epidemiology and outcome of glioblastoma","volume":"8","author":"Tamimi","year":"2017","journal-title":"Glioblastoma [Internet]."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0020","series-title":"StatPearls [Internet]","article-title":"Glioblastoma multiforme","author":"Kanderi","year":"2022"},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0025","first-page":"100","article-title":"Reactive azo compounds as a potential chemotherapy drugs in the treatment of malignant glioblastoma (GBM): Experimental and theoretical studies","volume":"10","author":"Akaninyene","year":"2022","journal-title":"J. Photochem. Photobio."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0030","doi-asserted-by":"crossref","first-page":"11999","DOI":"10.1039\/D0NJ05883A","article-title":"Anticancer activity, DNA binding and docking study of M(ii)-complexes (M = Zn, cu and Ni) derived from a new pyrazine\u2013thiazole ligand: synthesis, structure, and DFT","volume":"45","author":"Bera","year":"2021","journal-title":"New J. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0035","series-title":"Pyrazine derivatives: a patent review Expert Opinion on Therapeutic Patents","first-page":"33","volume":"25","author":"Martin","year":"2015"},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0040","first-page":"1","article-title":"A review on the medicinal importance of pyridine derivatives","volume":"1","author":"Altaf","year":"2015","journal-title":"J. Drug Des. Medic. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0045","series-title":"The Chemistry of Heterocycles: Structure, Reactions, Syntheses, and Applications","first-page":"257","article-title":"Six-membered heterocycles: sections 6.10\u20136.14","author":"Eicher","year":"2003"},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0050","doi-asserted-by":"crossref","first-page":"11110","DOI":"10.1021\/jo502096t","article-title":"Four-component Bicyclization approaches to skeletally diverse Pyrazolo[3,4-b]pyridine derivatives","volume":"79","author":"Tu","year":"2014","journal-title":"The J. of Org. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0055","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/cmdc.200700355","article-title":"Substituted Pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model","volume":"3","author":"Tuccinardi","year":"2008","journal-title":"ChemMedChem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1134\/S1019331610020061","article-title":"Developing state-of-the-art antiseptics based on pyridine derivatives","volume":"80","author":"Savchenko","year":"2010","journal-title":"Her. Russ. Acad. Sci."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0065","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00044-010-9440-0","article-title":"Synthesis and antimicrobial activity of new pyridine derivatives-I","volume":"20","author":"Patel","year":"2010","journal-title":"Med. Chem. R."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/1040841X.2010.512267","article-title":"Microbial metabolism of pyrazines","volume":"37","author":"Rajini","year":"2011","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0075","first-page":"990","article-title":"Synthesis, crystal structure and antifungal activity of N-(Pyridine-2-methyl)-2-(4-chlorophenyl)-3-methylbutanamide","volume":"28","author":"Chen","year":"2009","journal-title":"Jiegou Huaxue."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0080","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/ejic.200700030","author":"Vr\u00e1bel","year":"2007","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0085","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1007\/s00044-011-9903-y","article-title":"Antioxidant, cytotoxicity, and QSAR study of 1-adamantylthio derivatives of 3-picoline and phenylpyridines","volume":"21","author":"Worachartcheewan","year":"2012","journal-title":"Med. Chem. R."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2018.00178","article-title":"Highlights in BACE1 inhibitors for Alzheimer\u2019s disease treatment","volume":"6","author":"Coimbra","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furuta","year":"2009","journal-title":"Antiviral R."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0100","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1021\/jm0606342","article-title":"Dipyridyl Thiosemicarbazone chelators with potent and selective antitumor activity form Iron complexes with redox activity","volume":"49","author":"Richardson","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.181","article-title":"Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation","volume":"3","author":"Fokas","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0110","series-title":"Model Complexes for Copper\u2013Containing Enzymes. Concepts and Models in Bioinorganic Chemistry","author":"Kraatz","year":"2006"},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0115","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejmech.2018.05.023","article-title":"Two new cu(II) dipeptide complexes based on 5-methyl-2-(2\u2032-pyridyl)benzimidazole as potential antimicrobial and anticancer drugs: special exploration of their possible anticancer mechanism","volume":"154","author":"Qi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0120","first-page":"111","article-title":"In vitro and in vivo anti-proliferative activity and ultrastructure investigations of a copper(II) complex toward human lung cancer cell NCI-H460","volume":"210","author":"Leide","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0125","doi-asserted-by":"crossref","first-page":"9412","DOI":"10.1039\/D2DT00793B","volume":"51","author":"Varna","year":"2022","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0130","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s10973-017-6360-y","article-title":"Evaporation and decomposition of eutectics of cupric chloride and sodium chloride","volume":"129","author":"Shuiliang","year":"2017","journal-title":"J.Thermal Analys. Calorim."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0135","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/cmdc.201800533","article-title":"In silico prediction of blood-brain barrier permeability of compounds by machine learning and resampling methods","volume":"13","author":"Wang","year":"2018","journal-title":"ChemMedChem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J. Comb. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0150","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0155","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0160","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/jm015507e","article-title":"Simple selection criteria for drug-like chemical matter","volume":"44","author":"Muegge","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0165","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/anie.199515551","volume":"34","author":"Bernstein","year":"1995","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0170","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3892\/mmr.2013.1650","article-title":"Euphol arrests breast cancer cells at the G1 phase through the modulation of cyclin D1, p21 and p27 expression","volume":"8","author":"Wang","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/187152009787313837","article-title":"Copper complexes as anticancer agents","volume":"9","author":"Marzano","year":"2009","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0180","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2174\/138161210791164063","article-title":"Multi-targeted natural products evaluation based on biological activity prediction with PASS","volume":"16","author":"Lagunin","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0185","doi-asserted-by":"crossref","first-page":"0191838","DOI":"10.1371\/journal.pone.0191838","article-title":"CLC-Pred: a freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds","volume":"13","author":"Lagunin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0190","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0195","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0200","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fchem.2018.00362","article-title":"Prediction is a balancing act: importance of sampling methods to balance sensitivity and specificity of predictive models based on imbalanced chemical data sets","volume":"6","author":"Banerjee","year":"2018","journal-title":"Front Chem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/nar\/gku401","article-title":"ProTox: a web server for the in silico prediction of rodent Oral toxicity","volume":"42","author":"Drwal","year":"2014","journal-title":"Nuc. Acids Res."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0210","series-title":"CrysAlisPro 1.171.39.33c; Rigaku Oxford Diffraction","author":"Agilent Technologies","year":"2017"},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"SHELXT\u2014integrated space-group and crystal-structure determination","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. Sect. C Struct. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0220","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1107\/S0021889807067908","article-title":"Mercury: visualization and analysis of crystal structures","volume":"41","author":"Macrae","year":"2008","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jinorgbio.2022.112108_bb0225","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.3390\/ijms22063104","article-title":"Influence of complexation of Thiosemicarbazone derivatives with cu (II) ions on their antitumor activity against melanoma cells","volume":"22","author":"Pitucha","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016201342200397X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016201342200397X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:09:11Z","timestamp":1758985751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016201342200397X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":45,"alternative-id":["S016201342200397X"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2022.112108","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticancer and antimicrobial activity of new copper (II) complexes","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2022.112108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112108"}}